This inventor holds 2 USPTO granted patents and 1 published patent application and 3 EPO patents. Top assignees: Charité – Universitätsmedizin Berlin, Dendropharm Gmbh, Konrad-Zuse-Institut. Active years: 2015-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2015-2022
Title: Christoph Stein: Innovator in Analgesic Research
Introduction
Christoph Stein is a prominent inventor based in Berlin, Germany. He has made significant contributions to the field of analgesics, focusing on innovative approaches to pain management. With a total of 2 patents, his work is paving the way for new therapeutic options.
Latest Patents
Stein's latest patents include an "Analgesic preparation with nanocarriers and use thereof." This invention relates to a pharmaceutical composition that utilizes a hyperbranched polymer nanocarrier to enhance the efficacy of analgesics, particularly opioids like nalbuphine. The composition aims to primarily provide peripheral analgesic effects, thereby minimizing central side effects associated with traditional opioid use. Another notable patent is for "Fentanyl derivatives as pH-dependent opioid receptor agonists." This invention introduces fluorinated fentanyl derivatives that selectively activate opioid receptors in acidic environments, making them particularly effective in treating pain in inflamed tissues.
Career Highlights
Throughout his career, Christoph Stein has worked with esteemed institutions such as Charité – Universitätsmedizin Berlin and the Konrad Zuse Institute. His research has focused on developing innovative pain management solutions that address both efficacy and safety.
Collaborations
Stein has collaborated with notable colleagues, including Florian Paulus and Olga Scharkoi, contributing to the advancement of analgesic research through teamwork and shared expertise.
Conclusion
Christoph Stein's innovative work in analgesic research highlights the potential for new therapeutic strategies in pain management. His patents reflect a commitment to improving patient outcomes through advanced pharmaceutical compositions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile